Sole Source Purchase of SetPoint System for Treatment of RA Patients

The University of New Mexico/Hospital is seeking to purchase a SetPoint System, which includes a SetPoint Implant and a SetPoint Charger, for the treatment of RA patients. The system is designed to work by activating the body's innate pathways to restore the balance of the immune system, reducing inflammation. The proposed vendor is SetPoint Medical Corporation, and the purchase amount is $750,000. The term of the contract is 3 years with an option to renew. The sole source justification is that the SetPoint Therapy is the only FDA-approved, medical device-based treatment alternative for RA. * The purchase is for a SetPoint System, which includes a SetPoint Implant and a SetPoint Charger. * The system is designed to treat RA patients by reducing inflammation. * The proposed vendor is SetPoint Medical Corporation. * The purchase amount is $750,000. * The term of the contract is 3 years with an option to renew.